ICD-10-PCS table XXE
Measurement, Physiological Systems
Table rows
4 · Body Part
- 0Central Nervous
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 0Intracranial Vascular Activity, Computer-aided Assessment
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- 0Central Nervous
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 1Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification
7 · Qualifier
- ANew Technology Group 10
4 · Body Part
- 0Central Nervous
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 4Brain Electrical Activity, Computer-aided Semiologic Analysis
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 2Cardiac
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 1Output, Computer-aided Assessment
7 · Qualifier
- 9New Technology Group 9
4 · Body Part
- 2Cardiac
5 · Approach
- XExternal
6 · Device / Substance / Technology
- HCardiac Conduction Mechanism, Computer-aided Mapping for Planning
7 · Qualifier
- CNew Technology Group 12
4 · Body Part
- 3Arterial
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 2Pulmonary Artery Flow, Computer-aided Triage and Notification
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- 3Arterial
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 5Coronary Artery Flow, Quantitative Flow Ratio Analysis
- 6Coronary Artery Flow, Computer-aided Valve Modeling and Notification
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 2Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum
7 · Qualifier
- ANew Technology Group 10
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 3Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction
7 · Qualifier
- 8New Technology Group 8
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- 4Infection, Positive Blood Culture Small Molecule Sensor Array Technology
- 5Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability
7 · Qualifier
- ANew Technology Group 10
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- BInfection and Immune Response, Gene Expression Testing System
7 · Qualifier
- BNew Technology Group 11
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- VInfection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- 5Circulatory
5 · Approach
- XExternal
6 · Device / Substance / Technology
- YInfection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology
7 · Qualifier
- 9New Technology Group 9
4 · Body Part
- 9Nose
5 · Approach
- 7Via Natural or Artificial Opening
6 · Device / Substance / Technology
- UInfection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction
7 · Qualifier
- 7New Technology Group 7
4 · Body Part
- ZNone
5 · Approach
- XExternal
6 · Device / Substance / Technology
- AMacronutrient Content, Computer-aided Assessment for Nutrition Management
- CInfection, Computer-aided Triage and Notification
7 · Qualifier
- BNew Technology Group 11
All 18 valid codes in XXE
- XXE0X07Measurement of Intracranial Vascular Activity, Computer-aided Assessment, New Technology Group 7
- XXE0X1AMeasurement of Intracranial Cerebrospinal Fluid Flow, Computer-aided Triage and Notification, New Technology Group 10
- XXE0X48Measurement of Brain Electrical Activity, Computer-aided Semiologic Analysis, New Technology Group 8
- XXE2X19Measurement of Cardiac Output, Computer-aided Assessment, New Technology Group 9
- XXE2XHCMeasurement of Cardiac Conduction Mechanism, Computer-aided Mapping for Planning, New Technology Group 12
- XXE3X27Measurement of Pulmonary Artery Flow, Computer-aided Triage and Notification, New Technology Group 7
- XXE3X58Measurement of Coronary Artery Flow, Quantitative Flow Ratio Analysis, New Technology Group 8
- XXE3X68Measurement of Coronary Artery Flow, Computer-aided Valve Modeling and Notification, New Technology Group 8
- XXE5X2AMeasurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10
- XXE5X38Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8
- XXE5X4AMeasurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10
- XXE5X5AMeasurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
- XXE5XBBMeasurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11
- XXE5XV7Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7
- XXE5XY9Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9
- XXE97U7Measurement of Infection, Nasopharyngeal Fluid SARS-CoV-2 Polymerase Chain Reaction, New Technology Group 7
- XXEZXABMeasurement of Macronutrient Content, Computer-aided Assessment for Nutrition Management, New Technology Group 11
- XXEZXCBMeasurement of Infection, Computer-aided Triage and Notification, New Technology Group 11